Triple therapy in COPD: what we know and what we don't
PMA Calverley, H Magnussen… - COPD: Journal of …, 2017 - Taylor & Francis
Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) consists of an
inhaled corticosteroid (ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic …
inhaled corticosteroid (ICS), a long-acting β2-agonist (LABA) and a long-acting muscarinic …
Triple Therapy in COPD: What We Know and What We Don't.
PMA Calverley, H Magnussen, M Miravitlles… - COPD, 2017 - europepmc.org
Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) consists of an
inhaled corticosteroid (ICS), a long-acting β 2-agonist (LABA) and a long-acting muscarinic …
inhaled corticosteroid (ICS), a long-acting β 2-agonist (LABA) and a long-acting muscarinic …
Triple Therapy in COPD: What We Know and What We Don't
PMA Calverley, H Magnussen, M Miravitlles… - COPD, 2017 - pubmed.ncbi.nlm.nih.gov
Triple inhaled therapy for chronic obstructive pulmonary disease (COPD) consists of an
inhaled corticosteroid (ICS), a long-acting β 2-agonist (LABA) and a long-acting muscarinic …
inhaled corticosteroid (ICS), a long-acting β 2-agonist (LABA) and a long-acting muscarinic …